Cite
MLA Citation
Patrick Roth et al.. “RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA.” Neuro-oncology, vol. 20, n.d., pp. vi235–vi236. http://access.bl.uk/ark:/81055/vdc_100095486409.0x00001a